These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9246014

  • 1. Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis B virus.
    Levy M, Leibowich I, Zylber-Katz E, Ilan Y, Granit L, Sviri S, Caraco Y.
    Clin Pharmacol Ther; 1997 Jul; 62(1):6-14. PubMed ID: 9246014
    [Abstract] [Full Text] [Related]

  • 2. Dipyrone metabolism in liver disease.
    Zylber-Katz E, Caraco Y, Granit L, Levy M.
    Clin Pharmacol Ther; 1995 Aug; 58(2):198-209. PubMed ID: 7648770
    [Abstract] [Full Text] [Related]

  • 3. Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators.
    Levy M, Safadi R, Zylber-Katz E, Granit L, Caraco Y.
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):461-5. PubMed ID: 11699610
    [Abstract] [Full Text] [Related]

  • 4. Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics.
    Caraco Y, Zylber-Katz E, Granit L, Levy M.
    Arzneimittelforschung; 1993 Nov; 43(11):1204-8. PubMed ID: 8292065
    [Abstract] [Full Text] [Related]

  • 5. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
    Bahrami H, Daryani NE, Haghpanah B, Moayyeri A, Moghadam KF, Mirmomen S, Kamangar F.
    Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of intravenous levosimendan and its metabolites in subjects with hepatic impairment.
    Puttonen J, Kantele S, Ruck A, Ramela M, Häkkinen S, Kivikko M, Pentikäinen PJ.
    J Clin Pharmacol; 2008 Apr; 48(4):445-54. PubMed ID: 18303124
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
    Koçak N, Ozen H, Yüce A, Gürakan F.
    Turk J Pediatr; 1998 Apr; 40(3):365-72. PubMed ID: 9763900
    [Abstract] [Full Text] [Related]

  • 11. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD.
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
    Kumar M, Sharma BC, Sarin SK.
    J Gastroenterol Hepatol; 2008 Jun; 23(6):883-7. PubMed ID: 18070014
    [Abstract] [Full Text] [Related]

  • 13. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK, Ayaz C, Hosoglu S, Geyik MF, Ulug M.
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus.
    Huang YW, Hu CY, Chen CL, Liao YT, Liu CJ, Lai MY, Chen PJ, Yang SS, Hu JT, Chen DS, Kao JH.
    J Med Virol; 2009 Apr; 81(4):588-93. PubMed ID: 19235869
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Formation and excretion of dipyrone metabolites in man.
    Zylber-Katz E, Granit L, Levy M.
    Eur J Clin Pharmacol; 1992 Apr; 42(2):187-91. PubMed ID: 1618251
    [Abstract] [Full Text] [Related]

  • 19. Clinical and prognostic values of anti-hepatitis B core immunoglobulin M detection in asymptomatic hepatitis B surface antigen carriers.
    Ali HY, Faransawy ZE, Al-Megthab NA.
    Saudi Med J; 2002 Jul; 23(7):777-81. PubMed ID: 12174223
    [Abstract] [Full Text] [Related]

  • 20. [Difference and significance of peripheral blood T-lymphocyte subsets in patients with chronic hepatitis B and asymptomatic HBV carriers].
    Tian Y, Qiu ZF, Li TS.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 14; 85(47):3354-8. PubMed ID: 16409844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.